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Abstract
Background: Processing by c-secretase of many type-I membrane protein substrates triggers signaling cascades by
releasing intracellular domains (ICDs) that, following nuclear translocation, modulate the transcription of different genes
regulating a diverse array of cellular and biological processes. Because the list of c-secretase substrates is growing quickly
and this enzyme is a cancer and Alzheimer’s disease therapeutic target, the mapping of c-secretase activity susceptible gene
transcription is important for sharpening our view of specific affected genes, molecular functions and biological pathways.
Methodology/Principal Findings: To identify genes and molecular functions transcriptionally affected by c-secretase
activity, the cellular transcriptomes of Chinese hamster ovary (CHO) cells with enhanced and inhibited c-secretase activity
were analyzed and compared by cDNA microarray. The functional clustering by FatiGO of the 1,981 identified genes
revealed over- and under-represented groups with multiple activities and functions. Single genes with the most
pronounced transcriptional susceptibility to c-secretase activity were evaluated by real-time PCR. Among the 21 validated
genes, the strikingly decreased transcription of PTPRG and AMN1 and increased transcription of UPP1 potentially support
data on cell cycle disturbances relevant to cancer, stem cell and neurodegenerative diseases’ research. The mapping of
interactions of proteins encoded by the validated genes exclusively relied on evidence-based data and revealed broad
effects on Wnt pathway members, including WNT3A and DVL3. Intriguingly, the transcription of TERA, a gene of unknown
function, is affected by c-secretase activity and was significantly altered in the analyzed human Alzheimer’s disease brain
cortices.
Conclusions/Significance: Investigating the effects of c-secretase activity on gene transcription has revealed several
affected clusters of molecular functions and, more specifically, 21 genes that hold significant potential for a better
understanding of the biology of c-secretase and its roles in cancer and Alzheimer’s disease pathology.
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Introduction
c-Secretase is an unconventional aspartyl protease (composed of
PS1, NCT, Aph-1 and Pen2) with an intramembranous catalytic
site that is typical of the class of intramembrane-cleaving proteases
(I-CliPs) (for review, see [1,2]). Via the processing of its substrates
and freeing of their intracellular domains (ICDs), c-secretase
regulates a multitude of signaling pathways and biological processes
by influencing gene transcription. This is exemplified by the
processing of the Notch receptor and the Notch signaling pathway
(for a review, see [3]). After specific ectodomain shedding via tumor
necrosis factor a converting enzyme (TACE) (Fig. 1, step 1), Notch
is further cleaved intramembraneously by c-secretase (Fig. 1, step 2).
The intracellular domain of Notch (NICD) is freed to enter the
nucleus, where it interacts with the transcription factor CSL (Fig. 1,
step 3). With help from the coactivator Mastermind, CSL is
converted from a transcriptional repressor to a transcriptional
activator. CSL as an activator leads to the expression of Notch
target genes (Fig. 1, step 4), like the Hes or Hey family. Hes1, a
transcriptional repressor, inhibits the transcription of NC3C1 (Fig. 1,
step 5). Enhanced c-secretase activity, through its cleavage of Notch,
leads to increased transcription of specific genes (Fig. 1, step 4) that
repress the expression of other genes (Fig. 1, step 6) to influence a
multitude of biological processes. For example, the processing of
Notch by c-secretase is crucial for hepatoblast differentiation [4],
epidermis and hair follicle differentiation [5], alveolar differentia-
tion in mammary glands [6], maintenance of skin appendages [7],
intestinal stem cell specification [8], induction of satellite cells after
injury and maintenance [9] and neural specification of embryonic
stem cells [10].
The directions in which c-secretase activity can up- and down-
regulate gene transcription following its cleavage of a variety of
substrates is further exemplified by the processing of Amyloid-b
(Ab) precursor protein (APP), one of the better-known c-secretase
substrates. The successive processing of APP by BACE1 and c-
secretase indeed leads to the production of Ab peptides (a
causative agent in the pathogenesis of Alzheimer’s disease (AD)),
and APP-intracellular domains (AICDs) which, following associ-
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ation with the adaptor protein Fe65 and nuclear translocation, are
able to suppress the expression of the major Apolipoprotein e
(ApoE)/lipoprotein receptor LRP1 by binding directly to its
promoter [11]. Thus, APP processing is also involved in the
regulation of brain ApoE and cholesterol metabolism through
LRP1 [11]. As ApoE4 is the major known genetic risk factor for
late onset Alzheimer’s disease (LOAD) and since AICD produc-
tion depends on c-secretase, the latter is implicated in the sporadic
form as well. In contrast to LOAD, which correlates directly with
age, early onset familial Alzheimer’s disease (FAD) is genetic and is
mainly caused by mutations in presenilin1 or presenilin2 (PSEN1
or PSEN2), leading to loss of physiological or gain of toxic
functions. Murine specific loss of Psen1 in the forebrain has been
shown to affect certain aspects of memory [12,13]. However, it
remains difficult to correlate the loss of four murine PSEN alleles
with the mild single PSEN allele mutations in FAD [14,15]. c-
Secretase is thus directly or indirectly implicated in the
pathogenesis of both FAD and LOAD, making this protease an
attractive therapeutic target for the prevention and/or treatment
of AD. c-Secretase inhibitors/modulators have indeed reached
clinical phase III trials [16].
With an increasing number of reports about new c-secretase
substrates and the transcriptional effects of their ICDs being
potentially implicated in the pathogenesis of AD or several types of
cancer, we see a need for a basic overview of genes and molecular
functions that are transcriptionally affected by c-secretase activity.
Results
cDNA microarray analysis of genes differentially
transcribed in cells with enhanced c-secretase activity
In an effort to identify specific alterations of gene transcription
as a result of c-secretase activity, the transcriptomes of two CHO
cell lines (biological triplicates were used in each case) with
Figure 1. Microarray-based strategy for the identification of genes differentially transcribed in cells with enhanced c-secretase
activity. To identify genes whose transcription is affected by c-secretase activity, two starkly contrasting conditions were analyzed by cDNA
microarray: genetically engineered enhanced c-secretase (left panel) and pharmacologically inhibited c-secretase (right panel) in CHO cell lines. For a
schematic depiction of the strategy, the Notch-1 receptor signaling pathway is used as an example. After processing by the Furin protease and when
activated by binding to its ligands Notch-1 is cleaved at the S2 position by the TACE protease, generating a substrate for c-secretase (1, 7). Under
enhanced (left panel) or inhibited (right panel) c-secretase activity, the cleavage of the substrate controls the release of the Notch intracellular
domain (NICD) (2, 8). With enhanced c-secretase, increased numbers of NICDs enter the nucleus and interact with CSL (3), leading to the transcription
of target genes like Hes1 and Hey (4). The Hes1 transcription repressor inhibits transcription of target genes like NC3C1 (5), with the final
consequence being reduced production of NC3C1 mRNA (6). Thus, enhancing c-secretase leads simultaneously to gene-dependent increase (in the
case of Hes/Hey) or decrease (in the case of NC3C1) of mRNA copy numbers. With inhibited c-secretase, reduced numbers of NICDs (9) lead to the
transcription of less Hes1/Hey (10), to reduced inhibition of target genes like NC3C1 (11) and consequently to increased production of NC3C1 mRNA
(12). Inhibiting c-secretase thus leads to gene-dependent decrease (in the case of Hes/Hey genes) or increase (in the case of NC3C1) of mRNA copy
numbers. Following mouse cDNA microarray analysis of both transcriptomes, top scoring candidates were evaluated and validated by real time PCR
and further analyzed for changes of transcript levels between healthy and AD human brain cortices.
doi:10.1371/journal.pone.0006952.g001
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enhanced and inhibited c-secretase activity were analyzed and
compared (strategy depicted in Fig. 1 –exemplified by Notch
processing). The S-1 cell line overexpresses the four components of
c-secretase (NCT, Aph1a, PS1 and Pen2) and was characterized
by a marked increase in the level of PS1 heterodimers and an
associated 8-fold increase in c-secretase activity compared to
untransfected controls [17]. The other cell line consisted of the
original parental wild type CHO cells incubated with DAPT, a
well-known c-secretase inhibitor. We strategically chose those two
conditions, overexpression of c-secretase and inhibition of its
activity, to amplify the activity-dependent effects on gene
transcription levels (i.e., amplification of the signal from the
cDNA microarray). To reduce potential effects due to changes in
the protein levels of the c-secretase subunits as opposed to changes
in its activity that we are interested in, we used chemical inhibition
(DAPT) of c-secretase activity instead of gene silencing, which
ultimately leads to changes in protein levels [18]. Biological
functions have indeed been reported mainly for the c-secretase
subunit PS1, independently to the c-secretase activity. However,
because treatment of CHO cells with DAPT has been recently
reported to exacerbate the secretion of exosomes [19], we cannot
exclude at this stage that some detected genes may be exosome-
related in response to the DAPT treatment. The gene transcrip-
tion levels of the two cell lines were analyzed using a mouse cDNA
microarray (Fig. 1 and Material and Methods) [20] because of the
absence of a readily available DNA microarray based upon
hamster gene sequences or cDNA clones. This lack has been
noticed, and cross-species reactivity of a mouse microarray
hybridized with CHO-derived samples has been investigated
recently by De Leon Gatti et al. [21]. This group generated an
EST-based CHO microarray and compared it with results from a
mouse microarray and vice versa. They state that cross-species
hybridization yielded 89.6% overlap in their arrays, non-
contradicting results and led only to a decrease in sensitivity
resulting in detection of fewer differentially expressed genes.
Accordingly, we probably have not detected all differentially
expressed genes, but we have detected a significant amount,
including clusters of functional relevance. For example, Neprilysin,
an Ab-degrading enzyme of functional relevance to AD that has
been previously shown to be transcriptionally downregulated in
PSEN1/PSEN2 double knock out fibroblasts and to exhibit
reduced activity under chemical (DAPT) inhibition of c-secretase
in mouse neurons [22], was not detected in the current study.
Collectively, this supports the use of CHO cells with a mouse
microarray. The microarray data set discussed in this publication
has been deposited in the NCBI Gene Expression Omnibus
(GEO, http://www.ncbi.nlm.nih.gov/geo/) and is accessible
through GEO Series accession number GSE16379.
The mouse microarray consistently detected the four human c-
secretase subunits overexpressed in the S-1 cell line (Table 1). By
applying a cut-off based on the false discovery rate (FDR, i.e., the
probability to wrongly accept a difference between the two
conditions) with a p value of 0.005, we found 2658 EST clones
(1981 genes) to be differentially expressed, with 1241 EST clones
of increased and 1417 EST clones of decreased transcription upon
enhanced c-secretase activity (Supplemental Material, Dataset S1
and Dataset S2).
Functional clustering of genes differentially transcribed
in cells with enhanced c-secretase
Mapping clusters of genes of GO functions transcriptionally
susceptible to c-secretase activity levels resulted in a GO hierarchy-
dependent tree that will provide further orientation for c-secretase
research. Functional clustering of 2658 differentially expressed
sequences (1981 genes, Supplemental Material, Dataset S3) was
performed using the FatiGo tool [23]. Comparing the representa-
tion of functional groups of genes throughout the entire mouse
genome with their representation within the group of differentially
transcribed genes allowed us to see whether clusters of genes of a
specific functional group were enriched in the differentially
expressed set. Clusters of over- and underrepresented genes were
detected (Fig. 2). The gene functions ‘‘transcription regulator
activity’’, ‘‘kinase regulator activity’’, ‘‘catalytic activity’’ and
‘‘binding ’’ were found to be overrepresented among the 2658
sequences (1981 genes) that were differentially transcribed. The
cluster of ‘‘molecular transducer activity’’, through its subclusters in
the GO hierarchy: ‘‘receptor activity’’ GO0004872, ‘‘transmem-
brane receptor activity’’ GO 0004888 and ‘‘neurotransmitter
receptor activity’’ GO0030594, as well as the cluster of ‘‘transporter
activity’’, via its subcluster of ‘‘ion transporter activity’’
GO0015075, were underrepresented (Fig. 2, blue boxes). This is
significant since neurotransmitter activity and transmembrane
receptors are well within the focus of current AD research [24].
Supporting our hypothesis that c-secretase has a role in multiple
transcriptional regulatory activities, the GO cluster of ‘‘transcrip-
tion regulator activity’’ is overrepresented through both its
subclusters ‘‘transcriptional activator activity’’ GO0016563 and
‘‘transcriptional repressor activity’’ GO 0016564 (Fig. 2, red
boxes. Single member genes of each cluster are annotated in
Supplemental Material Dataset S3). A well-described gene within
the activator cluster is b-catenin (CTNNB1, FC=3, p= 0.001),
whereas an example of a gene in the cluster of ‘‘transcriptional
repressor activity’’ is HES1. Hes1 (FC=5.4, p = 7.69E-04) is a
transcription factor that has previously been reported as a
downstream target of the Notch signaling pathway [25] (Fig. 1).
Like the examples above, 56 other transcription-related genes
were found to be differentially transcribed with enhanced c-
secretase activity (Supplemental Material, Dataset S4). Consistent
with these findings, several known substrates of the enzyme were
detected on the microarray as well (Table 2). This suggests a
Table 1. Mouse microarray detection of c-secretase components overexpressed in CHO cells with enhanced c-secretase activity.
Gene Protein Probe ID FC adj.P.Val.
PSENEN presenilin enhancer 2 homolog (Pen2) H3153E12 17.1 2.01E-0.4
APH1A anterior pharynx defective 1 homolog A (Aph1a) H3009H07 8.1 2.29E-04
PSEN1 presenilin 1 (PS1) H3150D02 4.3 5.07E-04
NCSTN nicastrin (NCT) H3012F08 2.6 3.48E-02
Gene and Protein names are displayed in first and second column from the left; Probe IDs, fold change (FC) and adjusted P Value (for false discovery rate) follow in
columns 3, 4 and 5.
doi:10.1371/journal.pone.0006952.t001
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possible feedback mechanism by which the augmented processing
of these substrates by c-secretase might lead to their altered
transcription. The overrepresentation of genes in the clusters of
enzymatic activity, such as ‘‘kinase regulator activity’’ GO0019207
and ‘‘catalytic activity’’, through four distinct GO subclusters
(‘‘isomerase activity’’ GO 0016853, ‘‘ligase activity’’ GO0016874,
‘‘hydrolase activity’’ GO0016787 and ‘‘transferase activity’’ GO
00167740–Fig. 2, red boxes), is broad in terms of the type of
enzymatic activity and further shows the diversification of the
downstream effects of enhanced c-secretase activity.
The most complex cluster of molecular function that is
overrepresented among the differentially transcribed genes identified
in our microarray analysis is the GO function termed ‘‘Binding’’.
This cluster is overrepresented through six subclusters and several
subclusters of these (Fig. 2, lower part). Consistent with transcription
regulation, the binding subclusters of ‘‘nucleic acid binding’’
GO0003676 and ‘‘nucleotide binding’’ GO0000166 are overrepre-
sented. The cluster of ‘‘ion binding’’ GO0043167 is overrepresented
as well as the cluster of ‘‘protein binding’’ GO0005515. A
consistently overrepresented subcluster of the latter is ‘‘cytoskeletal
protein binding’’ GO0008092 (Fig. 2). Cytoskeletal proteins have
long been known to play a role in AD and Tauopathies. They are
targets of the cell polarity Wnt pathway, and their dynamics have
recently been shown to be affected by AICD [26].
‘‘Receptor binding’’ GO0005102 also includes the Notch ligand
and known c-secretase substrate Jagged 2 [27,28], as well as the a-
secretase ADAM 10 [29], four members of the Wnt family (Wnt6,
7a, 9b and 10a) and, the aforementioned b-catenin. Indeed, the
translocation of b-catenin is mediated by ADAM 10, which is of
the same functional cluster [30].
By clustering transcriptionally affected genes, we demonstrate
that neurotransmitter, transcription regulator and enzymatic
activities, transmembrane receptor and cytoskeletal proteins
functional groups are affected by c-secretase activity in their
mRNA copy numbers.
Validation of differential gene transcription by
quantitative real-time PCR
For specific analysis of single genes, the fifty most prominently
transcriptionally altered genes were evaluated by real time PCR.
Mouse code based primers worked reproducibly and specifically for
35 genes. Among them, 21 genes were found to be differentially
transcribed with enhanced c-secretase activity (Fig. 3 upper panel,
annotations lower panel). The highest increase in transcription
Figure 2. Functional clustering of differentially transcribed genes in cells with enhanced c-secretase activity. Categories within the
Molecular Function GO hierarchy that were over- and under- represented among the genes that were differentially transcribed in cells with enhanced
c-secretase activity. Red boxes display GO terms that were overrepresented; blue boxes indicate GO terms that were under-represented. Black boxes
represent main molecular functional clusters and arrows point toward according subclusters. The clustering of 1981 differentially transcribed genes
was performed with DAVID and the FatiGo tool [23].
doi:10.1371/journal.pone.0006952.g002
c-Secretase Gene Transcription
PLoS ONE | www.plosone.org 4 September 2009 | Volume 4 | Issue 9 | e6952
levels was detected for UPP1, a gene encoding an enzyme (Uridine
phosphorylase, UPase) directly implicated in the processing of
uridine. UPP1 was confirmed by real time PCR to have a 39.2-fold
increase in transcription levels (Fig. 3 upper panel). Uridine is a
strong sleep-promoter and is crucial for RNA, DNA and membrane
biosynthesis [31]. Because of the latter, a lack of uridine (caused by
increased UPase) would thus first damage cells with a large
membrane to cytoplasm ratio, one of the most extreme ratios being
found in neurons due to their axon and dendrite structure [32].
Interestingly oral administration of uridine has improved AD
phenotypes [33,34]. The protein Upp1 also interacts with Vimentin
[35], the distribution of which is characteristically altered in FAD
fibroblasts [36].
The Notch-dependent transcriptional repressor Hes1 was also
confirmed by real time PCR with a 7-fold increase in mRNA levels
under enhanced c-secretase activity (Fig. 3).
Importantly, we found several key players of the three Wnt
pathways to be transcriptionally altered in response to enhanced c-
secretase. We confirmed one of these, Wnt3a, to be increased by
2.8-fold in S-1 cells (Fig. 3). Aoyama et al. have reported that
Wnt3a can influence Notch protein levels and increase Notch1
activation [37], which increases the effect of enhanced c-secretase
even further through substrate enhancement. Thus, enhanced c-
secretase activity may lead to increased WNT3A transcription,
which in turn can increase the protein levels of the NICD-carrying
c-secretase substrate. This proposed enhancement of the canonical
Wnt pathway is further supported by the recent observation that
b-catenin (the central protein that also ties PS1 to the pathway)
modulates the level and transcriptional activity of Notch1/NICD
through their direct interaction [38]. Several proteins, including
Frizzled and Disheveled (Dvl), relay the Wnt signal along the
canonical pathway between Wnt and b-catenin. We found that
they both show increased gene transcription in our microarray
analysis. DVL3 was confirmed by qPCR to increase in mRNA
copy numbers by 3-fold (Fig. 3). Taken together with the
microarray data showing differential transcription of PROC,
DKK, LRP5/6, GBP, AXIN, b-catenin, C-JUN and CYC D (all
part of the canonical Wnt pathway–for further details see
‘Discussion’), our data suggest a strong transcriptional effect on
this pathway by c-secretase activity and resulting alterations in
gene expression. CYC D has also been reported to be
downregulated by Protein tyrosine phosphatase receptor type G
(PTPRG) [39]. We confirmed by real time PCR that PTPRG
transcript level is reduced by 515-fold (Fig. 3). AMN1 (levels down
978-fold) has also been connected with cell cycle regulation in
yeast, but its role in mammals is not well known. TERA, a gene of
unknown function (levels down 24-fold), has also been associated
with Wnt antagonism (see Fig. 3 and results of human cortex
analysis). b-actin served as housekeeping gene.
Protein interaction data suggest Wnt pathways as a
major target of c-secretase susceptible gene
transcription
In order to see whether c-secretase affects the transcription of
genes encoding interacting proteins, an interaction map of
encoded proteins was generated with the string 8.0 data bank
exclusively relying on evidence-based data. Clusters of protein
interactions suggest the Wnt signaling pathways as a major focus of
c-secretase-affected candidates (Fig. 4, highlighted in grey).
Indeed, we found several members of the canonical Wnt pathway,
but also some interactors of the planar cell polarity (PCP) pathway
and the Wnt/Ca2+ pathway, to have c-secretase activity
susceptible gene transcription (Fig. 4). Some of these genes have
been confirmed by real time PCR as well as DIGE experiments
(Egger et al., unpublished). The largest decrease in gene transcription
occurred for the gene encoding the protein Ptprg. This single-pass
type I membrane protein dephosphorylates protein tyrosine
phosphate and was recently suggested as a candidate tumor
suppressor gene in nasopharyngeal carcinoma [39]. The same
group reported functional evidence for a critical interaction of
Ptprg with the extracellular matrix, which induces cell arrest,
changes in cell cycle status and downregulation of cyclin D1 [39].
The latter is strongly affected by the canonical Wnt pathway.
Ptprzeta and beta, structurally similar to Ptprg, interact with Psd95
[40], which directly interacts with Wnt3a [41]. We could confirm
that WNT3A transcripts show an increase of 2.8-fold (Fig. 3).
Further, Wnt3a has also been reported to interact directly with
LRP1 (Fig. 4, lower right), a stimulator of the Wnt5a signaling
pathway [42] and a known c-secretase substrate tying c-secretase
to a major AD risk factor, ApoE [43]. Porcn, another protein that
interacts with Wnt3a [44], shows a three-fold increase in tran-
script level by the microarray experiment. Porcn also interacts
with Wnt 6 (4-fold increase in microarray) as reported by the same
group and is the first player of the canonical Wnt pathway as
displayed by the Kegg database (mmu04310, http://www.
genome.jp/dbget-bin/show_pathway?mmu04310). Wnt3a inter-
acts with Frizzled 1 [45], which showed a 5-fold increase in
mRNA levels by our microarray. Following the canonical Wnt
pathway, the first intracellular protein of the Wnt signaling
cascade is ‘‘Disheveled’’. As confirmed by real time PCR, DVL3
mRNA is increased by 3-fold with enhanced c-secretase activity.
Next, with the help of Gbp (microarray reports a 4-fold increase of
Gbp2), Gsk-3b is inhibited, which in turn inhibits b-catenin. As
made apparent by the graphical overview of interacting proteins
encoded by genes we found to be transcriptionally susceptible to c-
secretase activity, b-catenin plays a central role, linking different
proteins involved in different Wnt pathways (Fig. 4). Furthermore,
b-catenin has been found to function as a major node connecting
PS1 and several proteins that are encoded by genes that we found
to be differentially transcribed (Fig. 4). b-catenin transcription was
shown by the microarray to be 3-fold decreased. It interacts
directly with cdh15 (which showed a 2.4-fold increase in transcript
levels as confirmed by real time PCR, Fig. 3), with Cdh1 (a known
c-secretase substrate [46]), with PS1 (the c-secretase catalytic
subunit) and other proteins encoded by candidate genes reported
by the microarray. In the context of the canonical Wnt pathway,
Table 2. c-Secretase substrates as reported for differential
expression by microarray.
Gene ProbeID FC adj.P.Val.
LRP2 P869 8 7.48E-04
JAG2 N734 7 4.30E-03
APP* H3132G02 7 1.11E-03
NOTCH3 N732 5 2.78E-03
CDH1 H3050H02 23 4.26E-03
CD44 H3012H07 23 1.33E-03
EPHA4 H3122H01 23 4.82E-03
APLP2 H3154H04 24 2.22E-03
LRP1 H3105A05 25 2.75E-04
Lrp2, Jag2, App, Notch, Cdh1, CD44, Aplp2 and Lrp1 are known c-secretase
substrates and were found to have altered gene expression with enhanced
c-secretase activity.
*overexpressed in S-1 cells.
doi:10.1371/journal.pone.0006952.t002
c-Secretase Gene Transcription
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Figure 3. Real time PCR validation of differentially transcribed genes in cells with enhanced c-secretase activity. Fifty of the top
scoring genes identified by microarray analysis to be differentially transcribed with enhanced c-secretase activity were analyzed by real time PCR with
primers based on mouse gene sequences. These primers showed specific and reproducible amplification for 35 genes and a total of 21 genes were
validated to be differentially transcribed with enhanced c-secretase activity. Relative quantification is expressed as fold change of transcript levels
compared to inhibited c-secretase conditions. Fold difference is displayed on the Y-axis and in table below X-axis. Error bars reflect standard
deviations of biological triplicates.
doi:10.1371/journal.pone.0006952.g003
c-Secretase Gene Transcription
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b-catenin affects c-myc (CMYBP 3-fold increased on the
microarray), c-jun (3-fold decreased on the microarray) and cyclin
D (4-fold decreased on the microarray) - the latter, as mentioned,
is also downregulated by Ptprg. Dvl3 however also interacts with
other proteins encoded by candidate genes, among which Nkd1 is
of special interest since it links the canonical with the planar cell
polarity pathway where it has a different effect on Dvl. The Planar
cell polarity pathway through several players, among them Rac (3-
fold decreased on the microarray) affects gene transcription, as we
hypothesize for c-secretase activity changes. Through a chain of
different mediators, the planar cell polarity Wnt pathway affects
the cytoskeleton. Our microarray has reported some of these
mediators to be differentially transcribed as c-secretase activity is
enhanced; RhoA transcript levels for example are 3-fold
decreased. Rock, which is known to directly interact with the c-
secretase substrate CD44 (CD44/Rho Family GTPase/ROCK2)
[47,48], is transcriptionally affected too. Our top candidate UPP1
has only one interaction partner that was also reported to be
differentially expressed by the microarray, the cytoskeleton protein
vimentin (Vim) [35]. Vimentin itself is not new to AD research, as
altered Vim distribution patterns were observed in FAD fibroblasts
[36]. Also, UPP1 transcription is regulated by the transcription
factor Oct3/4, as is the transcription of another candidate, called
SPP1 [49]. Spp1 is a direct interaction partner of the
aforementioned c-secretase substrate CD44 and strongly affects
Ca2+ levels [50]. It directly interacts with several proteins encoded
by candidate genes, including PKCA, which itself directly interacts
with Aplp2, a well-known c-secretase substrate, and Csnk2b,
which directly interacts with b-catenin, thus closing the circle.
Csnk2b also directly interacts with Shmt1, which has enhanced
transcription of 3.5-fold (Fig. 3), and has been further confirmed in
DIGE experiments (Egger et al., unpublished). The third Wnt
pathway mentioned is the Wnt/Ca2+ pathway which includes,
among others, Plc (Plcb1 5-fold increase on the microarray),
CaMKII (4-fold decrease on the microarray) and Calpain (3-fold
decrease on the microarray).
Figure 4. Protein-protein interaction network of proteins encoded by genes differentially transcribed in cells with enhanced c-
secretase activity. All interaction partners as reported by experiment based evidence in the string 8.0 database are shown in black and indicated by
two headed arrows. Proteins encoded by PCR-validated genes are represented in circles (blue circles for genes of decreased transcription, red circles
for genes of increased transcription). Interaction partners encoded by genes identified in our microarray, but having not yet been validated are
displayed in quadrangles (blue quadrangles for genes of decreased transcription, red quadrangles for genes of increased transcription). Proteins with
blue background are known c-secretase substrates. The central grey box indicates c-secretase subunits. Proteins acting directly or indirectly on, or
interacting with Wnt pathways are highlighted by a light purple background figure.
doi:10.1371/journal.pone.0006952.g004
c-Secretase Gene Transcription
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Our mapping of genes differentially transcribed with c-secretase
activity shows that they encode proteins that directly interact with
each other, with many of them being members of Wnt pathways.
TERA gene transcription is significantly altered in
Alzheimer’s disease cortices
Our modeling of extreme levels of c-secretase activity in CHO
cells has revealed c-secretase-dependent differences in transcript
levels of specific genes. One of the major known risk factors for
developing Alzheimer’s disease is carrying the ApoE4 allele.
Recently it was shown that ApoE through LRP1 regulation is
connected with c-secretase [43], which supports the hypothesis of
a potential role of c-secretase in sporadic AD. c-Secretase is also
directly implicated in the inheritable familial early onset forms of
AD (FAD), as most cases are caused by mutations in PSEN1, the
gene encoding for PS1, the catalytic center of this enzyme.
To investigate whether changes in gene transcription that
coincide with alterations of c-secretase activity levels also differ
between sporadic Alzheimer’s and healthy human brain tissue, we
evaluated our top scoring c-secretase affected genes in human AD
and healthy cortices. Based on b-actin as housekeeping gene, we
found one c-secretase affected gene, TERA, to be significantly
differentially transcribed in the AD brain relative to the normal
brain. Real-time PCR results showed an average two-fold
increased TERA transcript levels (P2= 0.04) in human AD
cortices compared to healthy controls (Fig. 5).
Altogether, the Wnt antagonism gene TERA represents a new
candidate for differential expression with c-secretase activity as
well as in AD brain cortex tissue. Whether it is implicated in the
pathogenesis of AD requires further investigation.
Discussion
Since the discovery of the roles for NICDs and AICDs in gene
transcription, the notion of c-secretase as a major player in
pathologically altered gene transcription patterns has been steadily
gaining ground with new substrates and their transcriptionally
active ICDs being identified regularly. To investigate the impact of
c-secretase activity on gene transcription, we compared two starkly
contrasting situations: genetically engineered enhanced human c-
secretase activity and pharmacologically inhibited c-secretase
activity in CHO cell lines. By investigating the effects of enhanced
c-secretase activity on gene transcription using cDNA microarray
analysis, we could show that the canonical, the planar cell polarity
(PCP) and the Ca2+/Wnt pathways are transcriptionally affected
through more than a dozen of Wnt signaling players (summarized
in Fig. 6). From Proc and Wnt outside the membrane, through
Frizzled and Dvl, to b-catenin and down to cell cycle regulating
genes, the canonical Wnt pathway is the most affected of Wnt
pathways. Several genes of the PCP Wnt pathway as well as Ca2+/
Wnt pathways were found to be differentially expressed too (Fig. 6).
One of the cell cycle regulating genes is CYC-D, which itself is
Figure 5. Selected relative gene transcript levels in AD cortices. Real time PCR validated genes differentially transcribed in cells with
enhanced c-secretase activity were selected and their gene transcript levels analyzed in ten to twelve AD and healthy human cortical brain tissue
samples. Only the transcript levels of TERA, a gene of unknown function, is significantly altered with a two-fold increase in AD cortices. Note that
TERA transcript levels were significantly reduced in cells with enhanced c-secretase activity (Fig. 3). Relative quantification of gene transcription in
CHO cells as well as in brain tissue used b-actin as housekeeping gene. Healthy control levels are displayed on the left part of each diagram, AD
transcript levels on the right. Dashed lines indicate mean values for healthy controls (green) and AD cases (red). Double-headed arrows indicate
tendencies of differences between groups. P2 values obtained from t-test are indicated in black boxes of the upper part of each diagram.
doi:10.1371/journal.pone.0006952.g005
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regulated by one of the most c-secretase-dependently altered genes
reported by us, PTPRG.
Functional clustering of the microarray data revealed the
overrepresentation of the ‘‘receptor binding’’ cluster, which
includes four different Wnt signaling molecules and b-catenin. b-
Catenin also finds itself in the center of interactions of proteins
encoded by strongly differentially expressed genes. Components
downstream of the canonical Wnt pathway, like c-myc, c-jun and
cycD, influence the cell cycle, the latter as mentioned is down-
regulated by protein tyrosine phosphatase receptor type c (Ptprg).
Interestingly, we found PTPRG transcription to be strongly
decreased in cells with enhanced c-secretase. Barnea et al. [51]
identified a subfamily of PTPRs, defined by the carbonic
anhydrase-like domain in the extracellular region of PTPRG,
and described its expression during hippocampal formation, and
in septal and midline thalamic nuclei in the cortex of newborn rats
(in contrast to the expression pattern in adult rats, which is
reduced to the hippocampal formation). Several groups have
shown a connection between alterations in receptor tyrosine
phosphatases’ expression levels and c-secretase [52,53]. However,
we report here for the first time, to our knowledge, the
transcriptional connection between the receptor tyrosine phos-
phatase type gamma and c-secretase.
TERA, a gene that we found to be decreased in transcription
(down by 23.5-fold), has been connected to brain development and
Wnt antagonism as well. TERA is decreased to minimal transcript
levels with enhanced c-secretase activity (Fig. 3). This gene,
encoding a phosphoprotein of unknown function, is upregulated in
squamous cell carcinoma (SCC), adenocarcinoma (AC), and
colon, ovary, rectum and stomach tumors [54] (suggesting
associations with Notch?). It has also been reported that TERA
gene expression is increased in day 13 embryonic (E13) and
decreased in E17 cortex and maintains low, but consistent
expression levels in the subventricular zone (SVZ) [55]. The
expression pattern in earlier rather than later stages of brain
development and in the location of neuronal stem cell niches, like
the SVZ, suggest possible roles for Tera in regenerative processes
and raise questions about its function if the gene is being shut
down in degenerative disorders like AD [55]. Tera expression has
further been found to be maintained in neural progenitors and
downregulated during non-neural differentiation, and was shown
to have appreciable expression in embryonic stem cells in a screen
Figure 6. Involvement of c-secretase-dependently transcribed genes in Wnt pathways. Several key players of the canonical Wnt pathway
(green panel) were reported by our microarray to increase (red quadrangles) or decrease (blue quadrangles) in transcript levels under conditions of
enhanced c-secretase activity compared to inhibited activity. b-Catenin is a central node connecting Wnt–Frizzled–Dishevelled to a downstream
effect influencing the cell cycle (see also Fig. 4 and interactions of encoded proteins). For better understanding, selected genes that were not
detected by the microarray are displayed as well (dashed lines black quadrangles). CycD was reported to be regulated by PTPRG, one of the top
scoring candidates for c-secretase affected gene transcription. Nkd, which we found to be increased in transcript levels, connects the canonical Wnt
pathway with the planar cell polarity pathway (blue panel). CD44, a well-known c-secretase substrate, interacts with SPP1. SPP1 and UPP1, two strong
candidates are both under the control of the same transcription factor Oct3/4, as has been suggested for TERA [92]. UPP1 directly interacts with
Vimentin (see also Fig. 4), a known player in AD and a cytoskeletal protein. Crucial genes of the Wnt/Ca2+ pathway (grey panel) were also found to be
differentially expressed in our array. All together, c-secretase activity influences the transcript levels of genes of the canonical, the planar cell polarity
and Ca2+ Wnt pathways.
doi:10.1371/journal.pone.0006952.g006
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for functional genes in ES cells that implicated Wnt antagonism in
neural differentiation [56].
TERA and the anti-mitotic exit network antagonist 1 (AMN1)
map to chromosome 12p11, which is interesting when considering
the fact that chromosome 12 has been discussed to contain an
unknown LOAD locus for over a decade, and in a recent study
including 492 LOAD cases [57–59]. In our study, AMN1
transcription is decreased by 978-fold with enhanced c-secretase
activity. The function of AMN1 is not known. However, several
expression pattern based studies suggest it functions as a cilia gene
in sensory neurons [60]. Another typical cilia gene is intraflagellar
transport protein 81 (IFT81) which, among a dozen of known cilia
genes, was also shown by the microarray to be differentially
expressed with altered c-secretase activity (see also Fig. 3). More
and more evidence has been emerging over the last years that
primary cilia, in parallel to their well-established functions in sight,
smell and mechanosensation, are key participants in intercellular
signaling [61]. The importance of monocilia for the regeneration
of olfactory neurons has only been better understood recently [62].
Subventricular zone (SVZ) astrocytes, providing glia as well as
neurons for the mammalian olfactory bulb, have primary cilia
[63]. They give rise to type C cells, which in turn generate
neuroblasts [64] that migrate in the adult brain from the SVZ to
the olfactory bulb along the cerebrospinal fluid (CSF) flow. The
CSF flow depends on the beating of the ependymal cilia [65]. Cilia
genes are not only relevant to the maintenance of adult
regeneration in the brain since they uphold the constant flow of
the CSF, but also because they are directly implicated in cell cycle
control. Polycystins, for example, control the cell cycle through
three major pathways with one depending directly on b-catenin
[66]. A study of inversin has further shown that flow shear stress as
sensed through cilia may regulate the Wnt signaling pathway
through b-catenin [67,68]. Given that fluid flow is crucial for the
transport of neuroblasts in the SVZ, one could expect that b-
catenin and the Wnt signaling pathway that connects our
candidates are also functionally relevant to the cilia genes found
in this study. We found both genes of unknown function TERA
and AMN1 to be decreased in transcription with enhanced c-
secretase activity. TERA and AMN1 can be connected to neural
stem cells through several types of cancer, neural differentiation (in
the case of TERA) and through the role of monocilia for
neurogenesis (in the case of AMN1). All in all, we have
demonstrated that AMN1 and TERA are genes of basically
unknown function that are worthy of further investigation to
understand their roles in neurogenesis, cancer and c-secretase
biology.
We further report here that UPP1 transcript levels are increased
with enhanced c-secretase activity (by 39.2-fold). UPP1 encodes
for uridine phosphorylase (UPase), an enzyme that catalyzes the
reversible phosphorylytic cleavage of uridine and deoxyuridine to
uracil and ribose- or deoxyribose-1-phosphate [69]. UPP1
expression has been extensively connected to cancer, stem cells
and inflammation such as multiple sclerosis [70–77]. UPase is
induced by vitamin D3 and a mixture of inflammatory cytokines,
Interferon gamma, TNF-alpha and IL-1, with the latter two being
upregulators of Ptprg [78]. Increased UPP1 transcript levels,
associated with enhanced UPase activity cleaving uridine, would
potentially have inhibitory effects on several pathways downstream
of uridine, like RNA/DNA and membrane synthesis, as well as
protein glycosylation, which would in turn trigger long-term
neurodegeneration. Particularly, decreased membrane synthesis,
in the case of synaptic membranes, would also reduce synaptic
activity and plasticity. In support of that, TNF-a and IL-1,
inducers of UPP1, alter lipid metabolism and stimulate production
of eicosanoids, ceramide and reactive oxygen species that
potentiate CNS injuries and certain neurological disorders [33].
Interestingly, this hypothesis offers an explanation for the
multitude of beneficial effects of orally administered DHA and
uridine on memory, neuronal health, regeneration and membrane
synthesis in traumatic and chronic neuropathological conditions
[33,34].
The presented work demonstrates that c-secretase is capable of
influencing single gene transcription. However strong the impact
will prove to be on the protein level of each single gene, we have
further observed transcriptional effects spanning several genes
throughout clearly defined pathways. This puts forth the possibility
of much stronger effects on the target functions of these pathways
than the small impact on the individual genes transcriptional or
translational levels might indicate. In support of this hypothesis, we
have observed that the proteins encoded by those genes interact
with each other and are part of the Wnt pathways. Evaluation of
the impact of these pathway-specific accumulative effects needs
further investigation. This should include physiological and
pathological in vivo experiments on both the transcript as well as
protein levels. For c-secretase to serve as a therapeutic target, it is
indeed crucial to sharpen our view of its role and influence over
gene transcription and biological functions.
Materials and Methods
Cell culture
The S-1 cell line overexpressing Flag-Pen2, Aph1-a2-HA, PS1
and NCT-GST [17,79] was derived from the Chinese Hamster
Ovary (CHO) c-30 cell line [80] generated from the parental
untransfected CHO cell line used in this study. All CHO cells were
cultured in 10 cm dishes as biological triplicates in Dulbecco’s
modified Eagle’s medium (DMEM) containing 10% Fetal Bovine
Serum (FBS) and Penicillin/Streptomycin. The parental CHO cell
line was treated with 10 mM of N-[(3,5-Difluorophenyl)acetyl]-L-
alanyl-2-phenyl]glycine -1,1-dimethylethyl ester (DAPT) for
24 hrs. The S-1 cell line was supplemented with 200 mg/ml
G418, 25 mg/ml puromycin, 250 mg/ml zeocin, 250 mg/ml
hygromycin and 10 mg/mL blasticidin.
RNA amplification and microarray analysis
CHO parental cell line triplicates were exposed for 24 hrs to the
c-secretase inhibitor DAPT (10 mM) in DMSO (0.05%), and S-1
cells were treated for the same time with DMSO (0.05%). Cells
were next washed twice with PBS and total RNA was extracted,
amplified, reversely-transcribed, labeled and hybridized to a 17 k
mouse cDNA microarray chip produced by the DNA array facility
of Lausanne (DAFL, see below).
Total RNA extraction: was performed using the RNeasy Mini Kit
(Qiagen, Basel, Switzerland), in the absence of DNAse treatment.
RNA quality was assessed using the RNA 6000 Nanochip assay
(Agilent Technologies, Meno Park, USA) and RNA concentration
was determined using the ND-1000 spectrophotometer (Nanodrop
Technologies, Wilmington, USA). Three independent experi-
ments were performed.
RNA amplification: a single round of amplification was performed
with 3 mg of total RNA using the MessageAmp RNA Amplifica-
tion Kit (Ambion, Austin, USA) and following the protocol
provided with the kit. Next, 5 mg of amplified RNA was mixed
with 9 mg random primers (Cat. No. 4819001; Invitrogen,
Carlsbad, USA) in 19 ml of water, heated for 5 minutes at 70uC
and then immediately transferred to ice.
Reversed transcription and labeling: was performed for 2 hrs at 42uC
in a final reaction volume of 40 ml containing 1X SuperScript II
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buffer (Invitrogen), 40 units RNasin (Promega, Madison, USA),
10 mM DTT, 0.5 mM dATP, dGTP, dTTP, 0.2 mM dCTP,
0.1 mM of either Cy3-dCTP or Cy5-dCTP (GE Healthcare,
Uppsala, Sweden) and 400 units of SuperScript II reverse
transcriptase (Invitrogen). The RNA strand was hydrolyzed by
adding 2 ml 500 mM EDTA and 4.5 ml 1 M NaOH and heating
at 65uC for 15 minutes; the solution was then neutralized by
adding 2.5 ml 1 M Tris (pH 6.8) and 4.5 ml 1 M HCl. The labeled
cDNA was purified using the Qiagen MiniElute PCR Purification
Kit (Cologne, Germany), eluting in 50 ml of EB buffer according to
the manufacturer’s instructions. The Cy3 and Cy5 labeled targets
were combined and mixed with 400 ml of TE, 20 mg Cot 1 DNA
(Invitrogen), 10 mg polyadenylic acid (Sigma, St. Louis, USA) and
10 mg yeast tRNA (Sigma). This mixture was concentrated to a
final volume of 19.4 ml using a Microcon YM-30 filter (Millipore,
Billerica, USA) according to the manufacturer’s instructions. 20X
SSC and 10% SDS were added to final concentrations of 3X and
0.4%, respectively, in a final volume of 24 ml. This mixture was
heated for 2 minutes at 98uC, pipetted immediately onto the
cDNA microarray and, after covering with a glass cover slip (Erie
Scientific, Portsmouth, USA), placed in a humidified chamber
(Telechem, Sunnyvale, USA) and allowed to hybridize at 64uC for
20 hrs. Slides were then washed at room temperature twice for 5
minutes in 2X SSC, 0.1% SDS, twice for 1 minute in 0.2X SSC,
once for 1 minute in 0.1X SSC and once for 5 minutes in 0.1X
SSC, 0.1% Triton X-100. After drying, slides were scanned on a
microarray scanner (Agilent Technologies) and the resulting TIFF
images were analyzed using the GenePix Pro 6.0 software
(Molecular Devices, Sunnyvale, USA). The mouse cDNA micro-
arrays used in this study consisted of approximately 17,000 PCR
products generated from cDNA clones and control DNAs spotted
onto Nexterion AL slides (Schott, Mainz, Germany). A complete
description of the slides and their content can be obtained from the
Lausanne DNA Array Facility (http://www.unil.ch/dafl). The
microarray data set discussed in this publication has been
deposited in the NCBI Gene Expression Omnibus (GEO,
http://www.ncbi.nlm.nih.gov/geo/) and is accessible through
GEO Series accession number GSE16379. Note that Hamster
genomic sequence information is not yet sufficiently available to
the research community. Consequently no commercial hamster-
specific microarrays were available at the time of the experiment.
However, the strategy to use a microarray from a closely related
species is not new and has proven successful before [81].
Statistical analysis of microarray results
The analysis was performed with open source R software packages
(http://www.r-project.org/ and http://www.BioConductor.org/).
Gene expression was quantified with the array package using print
tip group lowess normalization without background subtraction. The
resulting measures of expression for each array are the log2 ratios (M
values) and the average log2 intensities (A value) of Cy3 and Cy5
signals. Statistics of differential expression between the different
groups of samples were calculated with a linear model fitted by the
limma package.
RNA isolation for evaluation of microarray results
Total RNA was isolated with the RNeasy mini kit following the
manufacturer’s protocol for adherent cells in the case of CHO cell
cultures. For the isolation of total RNA from brain tissue, the
TRIzol reagent was used as described in the human samples
section. RNA was dissolved in water, which was followed by ND-
1000 spectrophotometer (Nanodrop Technologies, Wilmington,
USA) quantification and pico chip quality control analysis (6000
Nanochip assay Agilent Technologies, Meno Park, USA).
Reverse Transcription
Total RNA was reverse transcribed with our standard
laboratory protocol. 1 mg of total RNA was dissolved in 4 ml of
RNase-free water (Ultrapure DNase/RNase free water, Invitrogen
Carlsbad, USA)) and premixed with 0.5 mg of oligo dT primer
(synthesized by Eurogentec Seraing, Belgium) dissolved in 1 ml
RNase-free water. The RNA/oligo dT premix was heated to 70uC
for 5 minutes in a standard PCR machine (TProfessional Basic
Gradient, Whatman Biometra Goettingen, Germany). The
machine was paused to add 4 ml of 5X Buffer (ImProm-II
M28A, Promega Madison USA), 4 ml of MgCl2 (25 mM)
(Promega Madison USA), 1 ml dNTP Mix (10 mM U151B,
Promega Madison USA), 1 ml RNase inhibitor (RNasin Plus
N261A 40 u/ul Promega Madison USA), 1 ml of ImProm-II
Reverse Transcriptase (Promega Madison, USA) and 4 ml RNase-
free water. The PCR machine program was continued after
pausing at 25uC for completion of reaction mixes with 60 min at
42uC and 15 min at 70uC. cDNA was kept at 4uC on wet ice for
short-term or at 280uC for long-term storage.
Real time PCR
Reverse transcription products were used without purification for
real time PCR at equivalent of 0.5 ng/ml RNA in 384 well plates.
Samples were used as biological triplicates and each one was
additionally pipetted as a triplicate. Reaction volumes were 10 ml
consisting of 5.02 ml SYBR Green (Power SYBR Green Master Mix
#4367660 Applied Biosystems, Cheshire UK), 1.49 ml RT-PCR
product at 0.5 ng/ml input RNA equivalent (0.75 ng/rxn) and 3.49 ml
of 3 mM Forward and Reverse primer mix. 384 well plates were
prepared with a liquid handling robot (Freedom EVOware Tecan
Trading AG, Switzerland) and read for relative quantification with
Applied Biosystems 7900HT Real-Time PCR System (Applied
Biosystems, Cheshire UK). Primers (synthesized by Eurogentec
Seraing, Belgium) for CHO cDNA were based on mouse code,
which was aligned with rat and human code, preference was given to
aligning sequences (Table 3). Sequence specificity was determined via
nBlast. b-actin was used as housekeeping gene [82–89] for CHO as
well as human cortex templates with the forward sequence:
CCTTCAACACCCCAGCCATGTACG and the reverse sequence:
CCTTCAACACCCCAGCCATGTACG.
Statistical analysis of real time PCR results
Results were analyzed by the DDCt method [90] and
significance was calculated via students t-test. b-actin was used a
normalizer to determine DCts. DDCts were calculated against the
mean of DAPT treated WT-CHO DCts or the mean of healthy
human brain cortex DCts. Results were expressed as relative
quantification by 2ˆ-(DDCt) [90].
Human samples
Human brain tissue was kindly provided by the Joseph and
Kathleen Bryan Alzheimer’s Disease Research Center, Duke
University Medical Center. The Autopsy and Brain Donation
procedures have been approved by the Duke University
Institutional Review Board (IRB) and cortical brain tissue was
obtained as described by [91]. 12 AD post-mortem confirmed
cortical samples as well as 12 healthy cortical samples were
obtained in dry ice. Cortical samples were of both genders,
different ages, ApoE stati and Brack stages.
Isolation of total RNA: ,50 ug of total cortex tissue were
scraped off on dry ice three times for biological triplicates of each
sample. TRIzol reagent (Invitrogen Carlsbad, USA) was used
according to manufacturer’s protocol for total RNA isolation.
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RNA was dissolved in water, which was followed by ND-1000
spectrophotometer (Nanodrop Technologies, Wilmington, USA)
quantification and pico chip quality control analysis (6000
Nanochip assay Agilent Technologies, Meno Park, USA).
Supporting Information
Dataset S1 EST clones with increased transcription under
enhanced c-scretase activity compared to inhibited c-secretase
activity. By applying a cut-off with a p value of 0.005 based on the
false discovery rate (FDR, i.e. the probability to wrongly accept a
difference between the two conditions), we found 2658 EST clones
to be differentially expressed, with 1241 EST clones of increased
with enhanced c-secretase activity compared to inhibited c-
secretase activity. FC=Fold change; adj,P,Val = adjusted P-value
Found at: doi:10.1371/journal.pone.0006952.s001 (0.20 MB
XLS)
Dataset S2 EST clones with decreased transcription under
enhanced c-secretase compared to inhibited c-secretase activity.
By applying a cut-off with a p value of 0.005 based on the false
discovery rate (FDR, i.e. the probability to wrongly accept a
difference between the two conditions), we found 2658 EST clones
to be differentially expressed, with 1417 EST clones of decreased
transcription with enhanced c-secretase activity compared to
inhibited c-secretase activity. FC=Fold change; adj,P,Val = ad-
justed P-value
Found at: doi:10.1371/journal.pone.0006952.s002 (0.22 MB
XLS)
Dataset S3 Molecular functional clusters of differentially
transcribed genes as classified in the GO hierarchy. Lists of genes
detected for differential transcription by the microarray, grouped
in clusters of molecular function as defined by the GO hierarchy.
Clusters are over- or underrepresented and do not indicate in- or
decrease of the genes transcription levels.
Found at: doi:10.1371/journal.pone.0006952.s003 (0.09 MB
DOC)
Dataset S4 EST clones of transcriptional relevance differentially
transcribed under enhanced c-secretase compared to inhibited c-
secretase activity. By applying a cut-off with a p value of 0.005 based on
the false discovery rate (FDR, i.e. the probability to wrongly accept a
difference between the two conditions), we found 2658 EST clones to
be differentially expressed with enhanced c-secretase activity compared
to inhibited c-secretase activity. Among them 56 imply transcriptional
relevance. FC=Fold change; adj,P,Val=adjusted P-value.
Found at: doi:10.1371/journal.pone.0006952.s004 (0.03 MB
XLS)
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Table 3. Sequences of primers used for real time PCR analysis with SYBR Green based on mouse code.
Gene Forward Reverse
UPP1 TCTACCATTTCAACCTCAGCACTAGCA CCATGGCTCACAGACAGCACG
CLCN5 ATGGACTTCTTGGAGGAGCCA GAGTTGAAGAGAATGGAATCAGGA
HES1 AAATGACTGTGAAGCACCTCCGG GTCATGCAGTTGGCCAGGTGG
HHEX CCGCTGTATGCGCCCACG GCGTGCGTGTAGTCGTTCACC
SHMT1 TCTTGCTTAAATAACAAATACTCTGAGGG GGCAGAGATTTTCTTCTTGTCTGTCAT
DVL3 GCTTCAATGGCCGGGTGG CACTGCTCTGTTCTGTGGAGCTGC
WNT3A CGAGGCCGGCGTTGGA GACTGGCGATGGCCTGGC
CHRD GGAGAGGGCTGCTATTTTGATGG TCTGATTCTCTGGGAACCACTGCC
CDH15 CGCGTGCGGAGGGCC GAAGCGATCAGTCTTCTCGCGG
MMP7 TAGGTGTGGAGTGCCAGATGTTGC CATGACCTAGAGTGTTCCCTGGCC
GLP1R ATAAGGACAACTCCAGCCTGCCC TGCTGGGCAGCCGTGCTATAC
PNLIPRP GCATCTGGGCGGGAACCC TATCAGCATAGTGACCCATCTGTGGG
FGF20 CCTGCACGGCATCCTGCG GTGCCCTGCACGCTGCC
PA2G4 CCAATAGAAGGTATGCTGTCACACCA AAGGGACCACTGGTTATCCGCATGG
NTSR1 GACGGCGTTCACGCTGGC AAGTTGTACAGCTCCACGGGCAT
SCT CCCAGGGCCCGGCG TCTGCGTCCTGCTCGCTGC
ITGBV CCTGTGCCGGGAGGCAGA GGCATTTGCATTCTCCACAGTGAC
IFT81 TGAGTTCAAGCGATACGTCA GTTGATGCTGAATGGTTTCC
TERA CAACCAGATCAGCAAACTGCAGAAG AGCCATCTCTGTATCTGAGCCCTCA
PTPRG TCTGGAGGATGATCTGGGAACAAAA CACCCATGTCAGGCCACTGTGT
AMN1 GACAATGGTGTGGTTGCACTTGTTAGT TGTTATCAGGGGGCAGCCATG
Primers were created for Tanneal of ,58–59uC and nBlast was used to check for gene specificity.
doi:10.1371/journal.pone.0006952.t003
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